Additionally, research indicating that global tau-PET signal intensity, rather than amyloid PET, predicts the rate of subsequent atrophy68 supports the notion that tau pathology could be a major driver of local neurodegeneration leading to atrophy in the AD brain. The gene discussed is MAPT; the disease is Alzheimer disease.